405 related articles for article (PubMed ID: 30334089)
1. Glycosylation control technologies for recombinant therapeutic proteins.
Gupta SK; Shukla P
Appl Microbiol Biotechnol; 2018 Dec; 102(24):10457-10468. PubMed ID: 30334089
[TBL] [Abstract][Full Text] [Related]
2. Glycoengineering of CHO Cells to Improve Product Quality.
Wang Q; Yin B; Chung CY; Betenbaugh MJ
Methods Mol Biol; 2017; 1603():25-44. PubMed ID: 28493121
[TBL] [Abstract][Full Text] [Related]
3. Glycoengineering of Mammalian Expression Systems on a Cellular Level.
Heffner KM; Wang Q; Hizal DB; Can Ö; Betenbaugh MJ
Adv Biochem Eng Biotechnol; 2021; 175():37-69. PubMed ID: 29532110
[TBL] [Abstract][Full Text] [Related]
4. Antibody glycoengineering strategies in mammalian cells.
Wang Q; Chung CY; Chough S; Betenbaugh MJ
Biotechnol Bioeng; 2018 Jun; 115(6):1378-1393. PubMed ID: 29457629
[TBL] [Abstract][Full Text] [Related]
5. Glycoengineering in CHO Cells: Advances in Systems Biology.
Tejwani V; Andersen MR; Nam JH; Sharfstein ST
Biotechnol J; 2018 Mar; 13(3):e1700234. PubMed ID: 29316325
[TBL] [Abstract][Full Text] [Related]
6. N-Glycosylation Design and Control of Therapeutic Monoclonal Antibodies.
Sha S; Agarabi C; Brorson K; Lee DY; Yoon S
Trends Biotechnol; 2016 Oct; 34(10):835-846. PubMed ID: 27016033
[TBL] [Abstract][Full Text] [Related]
7. Using glyco-engineering to produce therapeutic proteins.
Dicker M; Strasser R
Expert Opin Biol Ther; 2015; 15(10):1501-16. PubMed ID: 26175280
[TBL] [Abstract][Full Text] [Related]
8. Cellular engineering for therapeutic protein production: product quality, host modification, and process improvement.
Wells E; Robinson AS
Biotechnol J; 2017 Jan; 12(1):. PubMed ID: 27933725
[TBL] [Abstract][Full Text] [Related]
9. Glycosylation of therapeutic proteins in different production systems.
Werner RG; Kopp K; Schlueter M
Acta Paediatr; 2007 Apr; 96(455):17-22. PubMed ID: 17391433
[TBL] [Abstract][Full Text] [Related]
10. Glycosylation Analysis of Therapeutic Glycoproteins Produced in CHO Cells.
Carillo S; Mittermayr S; Farrell A; Albrecht S; Bones J
Methods Mol Biol; 2017; 1603():227-241. PubMed ID: 28493134
[TBL] [Abstract][Full Text] [Related]
11. Optimal and consistent protein glycosylation in mammalian cell culture.
Hossler P; Khattak SF; Li ZJ
Glycobiology; 2009 Sep; 19(9):936-49. PubMed ID: 19494347
[TBL] [Abstract][Full Text] [Related]
12. Escherichia coli as a glycoprotein production host: recent developments and challenges.
Jaffé SR; Strutton B; Levarski Z; Pandhal J; Wright PC
Curr Opin Biotechnol; 2014 Dec; 30():205-10. PubMed ID: 25156401
[TBL] [Abstract][Full Text] [Related]
13. Engineered CHO cells for production of diverse, homogeneous glycoproteins.
Yang Z; Wang S; Halim A; Schulz MA; Frodin M; Rahman SH; Vester-Christensen MB; Behrens C; Kristensen C; Vakhrushev SY; Bennett EP; Wandall HH; Clausen H
Nat Biotechnol; 2015 Aug; 33(8):842-4. PubMed ID: 26192319
[TBL] [Abstract][Full Text] [Related]
14. Glycoengineering Chinese hamster ovary cells: a short history.
Donini R; Haslam SM; Kontoravdi C
Biochem Soc Trans; 2021 Apr; 49(2):915-931. PubMed ID: 33704400
[TBL] [Abstract][Full Text] [Related]
15. Enhancement of recombinant human EPO production and glycosylation in serum-free suspension culture of CHO cells through expression and supplementation of 30Kc19.
Park JH; Wang Z; Jeong HJ; Park HH; Kim BG; Tan WS; Choi SS; Park TH
Appl Microbiol Biotechnol; 2012 Nov; 96(3):671-83. PubMed ID: 22714097
[TBL] [Abstract][Full Text] [Related]
16. Humanizing glycosylation pathways in eukaryotic expression systems.
Khan AH; Bayat H; Rajabibazl M; Sabri S; Rahimpour A
World J Microbiol Biotechnol; 2017 Jan; 33(1):4. PubMed ID: 27837408
[TBL] [Abstract][Full Text] [Related]
17. Emerging technologies for making glycan-defined glycoproteins.
Wang LX; Lomino JV
ACS Chem Biol; 2012 Jan; 7(1):110-22. PubMed ID: 22141574
[TBL] [Abstract][Full Text] [Related]
18. N-glycosylation engineering of biopharmaceutical expression systems.
Jacobs PP; Callewaert N
Curr Mol Med; 2009 Sep; 9(7):774-800. PubMed ID: 19860659
[TBL] [Abstract][Full Text] [Related]
19. Supplementing glycosylation: A review of applying nucleotide-sugar precursors to growth medium to affect therapeutic recombinant protein glycoform distributions.
Blondeel EJM; Aucoin MG
Biotechnol Adv; 2018; 36(5):1505-1523. PubMed ID: 29913209
[TBL] [Abstract][Full Text] [Related]
20. Cell culture media supplementation of infrequently used sugars for the targeted shifting of protein glycosylation profiles.
Hossler P; Racicot C; Chumsae C; McDermott S; Cochran K
Biotechnol Prog; 2017 Mar; 33(2):511-522. PubMed ID: 28019688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
